Additionally, we observed increased mTORC2-independent signaling effects of Rictor overexpression in gliomas from GFAP-Cre/RictorloxP/loxP mice and in cell lines established from these tumors (see Figure 3). The gene discussed is GFAP; the disease is central nervous system cancer.